Background To elucidate the clinical and ancillary features of genetic prion diseases (gPrDs) presenting with frontotemporal dementia (FTD) to aid early identification. Methods Global data of gPrDs presenting with FTD caused by prion protein gene mutations were collected from literature review and our records. Fifty-one cases of typical FTD and 136 cases of prion diseases admitted to our institution were included as controls. Clinical and ancillary data of the different groups were compared. Results Forty-nine cases of gPrDs presenting with FTD were identified. Compared to FTD or prion diseases, gPrDs presenting with FTD were characterized by earlier onset age (median 45 vs. 61/60 years, P < 0.001, P < 0.001) and higher incidence of positive family history (81.6% vs. 27.5/13.2%, P < 0.001, P < 0.001). Furthermore, GPrDs presenting with FTD exhibited shorter duration (median 5 vs. 8 years) and a higher rate of parkinsonism (63.7% vs. 9.8%, P < 0.001), pyramidal signs (39.1% vs. 7.8%, P = 0.001), mutism (35.9% vs. 0%, P < 0.001), seizures (25.8% vs. 0%, P < 0.001), myoclonus (22.5% vs. 0%, P < 0.001), and hyperintensity on MRI (25.0% vs. 0, P < 0.001) compared to FTD. Compared to prion diseases, gPrDs presenting with FTD had a longer duration of symptoms (median 5 vs. 1.1 years, P < 0.001), higher rates of frontotemporal atrophy (89.7% vs. 3.3%, P < 0.001), lower rates of periodic short-wave complexes on EEG (0% vs. 30.3%, P = 0.001), and hyperintensity on MRI (25.0% vs. 83.0%, P < 0.001). The frequency of codon 129 Val allele in gPrDs presenting with FTD was significantly higher than that reported in the literature for gPrDs in the Caucasian and East Asian populations (33.3% vs. 19.2%/8.0%, P = 0.005, P < 0.001). Conclusions GPrDs presenting with FTD are characterized by early-onset, high incidence of positive family history, high frequency of the Val allele at codon 129, overlapping symptoms with prion disease and FTD, and ancillary features closer to FTD. PRNP mutations may be a rare cause in the FTD spectrum, and PRNP genotyping should be considered in patients with these features.
基金：
Ministry of Science and Technology of China [2019YFC0118600]; National Natural Science Foundation of China [81971011]; Beijing Municipal Science and Technology Committee [D171100008217005, 7202060]
第一作者机构：[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
通讯作者：
推荐引用方式(GB/T 7714)：
Chen Zhongyun,Chu Min,Liu Li,et al.Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge[J].ALZHEIMERS RESEARCH & THERAPY.2022,14(1):doi:10.1186/s13195-022-01033-4.
APA：
Chen, Zhongyun,Chu, Min,Liu, Li,Zhang, Jing,Kong, Yu...&Wu, Liyong.(2022).Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge.ALZHEIMERS RESEARCH & THERAPY,14,(1)
MLA：
Chen, Zhongyun,et al."Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge".ALZHEIMERS RESEARCH & THERAPY 14..1(2022)
医学